4
Changes in Ownership
GENELUX Corp Filed Acc 0001415889-25-012807
VP, Clinical Trial Operations sold 5,579 shares at $2.92 ($16,291)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Yu Yong VP, Clinical Trial Operations | 2025-05-12 | Sale | −5,579 | $2.92 | $16,291 | 47,640 | D |
| Open-market sales · 5,579 sh · avg $2.92 · $16,291 | |||||||
Loading xslF345X05/form4-05132025_050533.xml…